ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Intestinal Microbiome
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1565887
This article is part of the Research TopicMulti-Scale Systems: Ecological Approaches to Investigate the Role of the Microbiota in Different NichesView all 7 articles
Long-Term Alterations in Gut Microbiota Following Mild COVID-19 Recovery: Bacterial and Fungal Community Shifts
Provisionally accepted- 1Hainan Medical University, Haikou, China
- 2Hainan Second People's Hospital, Wuzhishan, Hainan Province, China
- 3Wuzhishan Center for Disease Control and Prevention, Wuzhishan, China
- 4Ledong Second People's Hospital, Ledong, China
- 5Dongfang People's Hospital, Dongfang, China
- 6Department of Gastroenterology, Qionghai People's Hospital, Qionghai, China
- 7Otog Front Banner People 's Hospital, Otog Front Banner, China
- 8Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan Province, China
- 9Department of Gastroenterology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China
- 10The Gastroenterology Clinical Medical Center of Hainan Province, HaiKou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
COVID-19 has had a profound impact on public health globally. However, most studies have focused on patients with long COVID or those in the acute phase of infection, with limited research on the health of individuals who have recovered from mild COVID-19. This study investigates the long-term changes in bacterial and fungal communities in individuals recovering from mild COVID-19 and their clinical relevance. Healthy individuals from Hainan Province were enrolled before the COVID-19 outbreak, along with individuals recovering from COVID-19 at 3 months and 6 months post-recovery. Stool, blood samples, and metadata were collected. Metagenomic sequencing and Internal Transcribed Spacer (ITS) analysis characterized bacterial and fungal communities, while bacterial-fungal co-occurrence networks were constructed. A random forest model evaluated the predictive capacity of key taxa. The gut microbiota of COVID-19 recoverees differed significantly from that of healthy individuals. At 3 months post-recovery, probiotics (e.g., Blautia massiliensis and Kluyveromyces spp.) were enriched, linked to improved metabolism, while at 6 months, partial recovery of probiotics (e.g., Acidaminococcus massiliensis and Asterotremella spp.) was observed alongside persistent pathogens (e.g., Streptococcus equinus and Gibberella spp.). Dynamic changes were observed, with Acidaminococcus massiliensis enriched at both baseline and 6 months but absent at 3 months. Co-occurrence network analysis revealed synergies between bacterial (Rothia spp.) and fungal (Coprinopsis spp.) taxa, suggesting their potential roles in gut restoration. The bacterial random forest model (10 taxa) outperformed the fungal model (8 taxa) in predicting recovery status (AUC = 0.99 vs. 0.80). These findings highlight the significant long-term impacts of mild COVID-19 recovery on gut microbiota, with key taxa influencing metabolism and immune regulation, supporting microbiome-based strategies for recovery management.
Keywords: Mild COVID-19, gut microbiome, metagenomic sequencing, Probiotics, Fungal microbiota, random forest model, ROC curve analysis, Bacterial-fungal co-occurrence network
Received: 23 Jan 2025; Accepted: 17 Apr 2025.
Copyright: © 2025 Li, Zhang, Chen, Lv, Huang, Chen, Zeng, Chen, Zhang, Xiong, Chen, Jiang, Chen, Mo, Chen, Zhu, Zhang and Bai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Feihu Bai, Department of Gastroenterology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.